Search

Search Constraints

You searched for: Author/Creator Basset, Marco

Search Results

1. 591 SEQUENCE OF DIAGNOSTIC TESTING IN CARDIAC AMYLOIDOSIS: EARLY MONOCLONAL PROTEIN STUDY IS ASSOCIATED WITH BETTER OUTCOMES IN AL AMYLOIDOSIS. (15th December 2022)

4. Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis. (2nd July 2020)

5. CT features in amyloidosis of the respiratory system – Comprehensive analysis in a tertiary referral center cohort. Issue 129 (August 2020)

6. Daratumumab, lenalidomide, and dexamethasone in systemic light‐chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21. Issue 7 (3rd May 2021)

7. High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate. Issue 8 (30th April 2020)

8. Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis. (16th March 2017)

9. Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow‐up. (3rd August 2021)

10. Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression. Issue 10 (12th August 2020)